Risk of malignancy index as an evaluation of preoperative pelvic mass

Authors

  • Bouzari Zinatossadat
  • Shahla Yazdani
  • Narges Abbaszadeh
  • Ziba Shirkhani Kelagar
Abstract:

Background: Risk of malignancy index (RMI) is the best method for discriminating benign and malignant pelvic masses. The aim of this study was to determine the RMI for preoperative evaluation of pelvic mass. Methods: This study was performed on 182 women with adenexal mass referred to Yahyahnejiad Hospital of Babol University of Medical Sciences in Iran from 2007 to 2009.The sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of menopausal status, ultrasound finding of pelvic mass and level of serum CA-125, separately or combined into the RMI were calculated and compared. Results: The mean age of patients was 39.9±9.3 years. The RMI with the cut-off point of 265 had a sensitivity of 91.3%, specificity of 96.2 %, PPV of 77.7% and NPV of 98.7% for diagnosis of malignant masses. Conclusion: Risk of malignancy index should be an effective method for evaluating a patient with adnexal masses before operation and a cut-off point of 265 which has a very high sensitivity, specificity and positive and negative predictive values for discriminating malignant and benign pelvic masses.

Download for Free

Sign up for free to access the full text

Already have an account?login

similar resources

risk of malignancy index as an evaluation of preoperative pelvic mass

background: risk of malignancy index (rmi) is the best method for discriminating benign and malignant pelvic masses. the aim of this study was to determine the rmi for preoperative evaluation of pelvic mass. methods: this study was performed on 182 women with adenexal mass referred to yahyahnejiad hospital of babol university of medical sciences in iran from 2007 to 2009.the sensitivity, specif...

full text

Risk of malignancy index in preoperative evaluation of pelvic masses.

OBJECTIVE The aim of this study was to evaluate the use of risk of malignancy index (RMI) based on a serum CA125 level, ultrasound findings and menopausal status in primary evaluation of patients with adnexal masses in daily clinical practice. METHODS One hundred and fifty one women with adnexal masses were enrolled. Ultrasound characteristics, menopausal status and serum CA125 level were doc...

full text

preoperative evaluation of risk of ovarian malignancy algorithm index in prediction of malignancy of adnexal masses

results: the only significant difference was the older age of the malignant group vs. benign group (p = 0.001) regarding demographic findings. as concerns the clinical symptoms, presence of abdominal discomfort in pre-diagnosis period was the only significant parameter in malignant group (p = 0.001). additionally, data analysis of patients as a total group showed that specificity (96.4%), posit...

full text

Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass.

BACKGROUND The discrimination between benign and malignant adnexal masses is central to decisions regarding clinical management and surgical planning in such patients. PURPOSE OF STUDY To determine if the RMI (RMI 2) can distinguish between benign and malignant adnexal masses. METHODS A prospective cohort study was conducted of 58 women with an adnexal mass referred to a teaching hospital f...

full text

Preoperative Evaluation of Risk of Ovarian Malignancy Algorithm Index in Prediction of Malignancy of Adnexal Masses

BACKGROUND Differentiation between benign and malignant ovarian neoplasms is essential to create a system for patient referrals. OBJECTIVES The aim of the present prospective trial was to analyze the value of the risk of ovarian malignancy algorithm (ROMA) in prediction of adnexal masses malignancy in pre- and post-menopause women before operation. MATERIALS AND METHODS Preoperative serum s...

full text

Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass.

OBJECTIVES To evaluate the validity and compare the performance of cancer antigen-125 (CA-125), human epididymis protein 4 (HE4), the risk of malignancy index (RMI), and the risk of ovarian malignancy algorithm (ROMA) in the diagnosis of ovarian cancer in patients with ovarian lesions discovered during their preoperative work-up investigations. METHODS This prospective, cross-sectional study ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue None

pages  331- 335

publication date 2011-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023